PTI Wednesday the US pharma giant and the Centre have held a series of meetings to fast-track approval for the Pfizer-BioNTech vaccine.The vaccine, Pfizer told the government, has been proven suitable for children over the age of 12.
It has been cleared for use on 12-15-year-olds in the United States and Canada.Never miss a story! Stay connected and informed with Mint.